Daniel A. Monaco



(215) 988-3312 phone
(215) 988-2757 fax

Daniel A. Monaco is a partner in the firm's Intellectual Property Practice Group and Co-Chair of the Intellectual Property Life Sciences Team. Formerly a shareholder with the Philadelphia intellectual property law firm of Seidel, Gonda, Lavorgna & Monaco, P.C., Dan joined Drinker Biddle & Reath when the two firms combined practices in 2001. He has been a registered patent attorney since 1981.

Intellectual Property. Dan has extensive experience in all aspects of intellectual property law. Concentrating on patent practice, Dan has prepared and prosecuted hundreds of U.S. patent applications, primarily in chemistry and biotechnology. He has represented diverse business and academic clients in matters pertaining to chemistry and chemical engineering. Representative chemical technologies include polymers, high performance coatings, chemical formulations, forestry products and industrial chemical processes; human and veterinary health care products, particularly pharmaceuticals such as anticancer, antithrombotic and antiviral drugs; methods and compositions for liquid lung ventilation in neonates; dental products; controlled delivery of pharmaceuticals, such as transdermal drug delivery; and diagnostic in vivo imaging of tumors and thrombi.

Dan has also represented clients in a broad spectrum of biotechnology applications from anticancer therapies and biopharmaceuticals to molecular genetics/biology and clinical diagnostics. Representative biological technologies include immunology; cancer vaccines, for example genetically engineered antitumor cellular immunogens; antisense oligonucleotide therapies; gene therapies, particularly targeted alteration of genes to correct genetic defects; nuclear transfer, cloning and the production of transgenic animals; generation of null mutant transgenic animals as disease models; monoclonal antibody technologies; genetic engineering of microorganisms; molecular genetic-based diagnostic methods; novel DNA and expressed proteins; peptide drugs, particularly antithrombotic and anticancer drugs; artificial blood substitutes; and agrobiotechnology.

Dan has represented major academic and business clients, individuals and startup companies in the Delaware Valley and elsewhere, before the United States Patent and Trademark Office and the federal courts. He has also prepared and negotiated numerous agreements involving the licensing of intellectual property rights. Working through an extensive network of overseas associates, Dan has counseled clients extensively in international patent protection, and has obtained extensive foreign patent protection for a wide variety of clients. He has also served as an expert witness during biotechnology litigation.

Publications. Dan is the co-author of What the General Practitioner Should Know About Patent Law and Practice, American Law Institute – American Bar Association Committee on Continuing Professional Education.

In General. Dan is a member of the Philadelphia, Pennsylvania and American Bar Associations, the American Intellectual Property Law Association, and the American Chemical Society.

Daniel has been ranked by Chambers USA since 2004 in Intellectual Property Law, recognizing him as "a skilled attorney who is great at building client relationships." He was honored as Best Lawyers® Philadelphia Patent Lawyer of the Year for 2015.

New Jersey Tech News
Pitfalls of Provisional Patent Applications